格拉替雷 (Copaxone)

Glatiramer Acetate

生产企业：Teva Pharmaceutical Industries Ltd.

Glatiramer acetate is an immunomodulator medication used to treat multiple sclerosis.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Glatiramer acetate is an immunomodulator medication used to treat multiple sclerosis.

用于治疗复发型多发性硬化症（MS/罕见病），包括成人临床孤立综合征、复发-缓解性疾病和活动性继发进行性疾病。

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Low frequency glatiramer acetate therapy
US 8399413 B2申请人: KLINGER ETY优先权: 2009
CN
US
13 件公开
Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
US 7074580 B2申请人: YEDA RES & DEV优先权: 2001
US
11 件公开
Analysis of amino acid copolymer compositions
US 8329391 B2申请人: ZHU XIANGPING优先权: 2009
US
11 件公开
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR POLYPEPTIDE MIXTURES
EP 3290432 A4申请人: HYBIO PHARMACEUTICAL CO LTD优先权: 2015
CN
EP
US
WO
9 件公开
Processes for preparing a polypeptide
US 2006154862 A1申请人: RAY ANUP K优先权: 2005
CN
US
8 件公开
Process for the measurement of the potency of glatiramer acetate
US 7429374 B2申请人: TEVA PHARMA优先权: 2002
US
8 件公开
PROCESS FOR PREPARING MICROPARTICLES CONTAINING GLATIRAMER ACETATE
- EP 3503907 C0
  申请人: MAPI PHARMA LTD优先权: 2016
  CN
  EP
  US
  WO
  6 件公开
- US 12097292 B2
  申请人: MAPI PHARMA LTD优先权: 2022
  US
DEPOT SYSTEMS COMPRISING GLATIRAMER ACETATE
EP 3506921 A1申请人: MAPI PHARMA LTD优先权: 2016
CN
EP
US
WO
6 件公开
Methods of evaluating diethylamide in glatiramer acetate
US 8470603 B2申请人: SHRIVER ZACHARY优先权: 2007
US
6 件公开
GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS
EP 3600553 B1申请人: MAPI PHARMA LTD优先权: 2017
CN
EP
US
5 件公开